The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Barker, Stephen George Edward
    Medical Doctor born in January 1960
    Individual (10 offsprings)
    Officer
    2014-05-08 ~ now
    OF - Director → CIF 0
    Mr Stephen George Edward Barker
    Born in January 1960
    Individual (10 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 2
    Allan, William David, Dr
    Director born in May 1958
    Individual (8 offsprings)
    Officer
    2021-03-01 ~ now
    OF - Director → CIF 0
  • 3
    Clarence House, Clarence Street, Manchester, England
    Active Corporate (4 parents, 6 offsprings)
    Person with significant control
    2018-05-09 ~ now
    PE - Has significant influence or control → CIF 0
  • 4
    QUESTER VENTURE MANAGERS LIMITED - 2010-04-22
    PARQUEST CAPITAL MANAGEMENT LIMITED - 2001-01-12
    AMPLEPINE LIMITED - 1989-02-27
    131, Mount Pleasant, Liverpool, England
    Active Corporate (2 parents, 4 offsprings)
    Profit/Loss (Company account)
    41,321 GBP2023-01-01 ~ 2023-12-31
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% as a member of a firm → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% as a member of a firm → CIF 0
Ceased 3
  • 1
    Carson, Robert John
    Chief Executive Officer born in July 1971
    Individual (1 offspring)
    Officer
    2013-12-23 ~ 2024-11-05
    OF - Director → CIF 0
  • 2
    Edwards, Alan
    Director born in February 1948
    Individual (4 offsprings)
    Officer
    2014-05-08 ~ 2021-09-13
    OF - Director → CIF 0
  • 3
    Liverpool Science Park 131, Mount Pleasant, Liverpool, Merseyside, United Kingdom
    Dissolved Corporate (2 parents, 4 offsprings)
    Equity (Company account)
    1 GBP2021-12-31
    Officer
    2014-05-08 ~ 2016-08-11
    PE - Director → CIF 0
parent relation
Company in focus

NEWTEC VASCULAR PRODUCTS LIMITED

Standard Industrial Classification
32500 - Manufacture Of Medical And Dental Instruments And Supplies
Brief company account
Average Number of Employees
32023-01-01 ~ 2023-12-31
32022-01-01 ~ 2022-12-31
Intangible Assets
1,407,997 GBP2023-12-31
1,278,297 GBP2022-12-31
Fixed Assets
1,407,997 GBP2023-12-31
1,278,297 GBP2022-12-31
Debtors
Current
50,804 GBP2023-12-31
52,534 GBP2022-12-31
Cash at bank and in hand
59,658 GBP2023-12-31
97,513 GBP2022-12-31
Current Assets
110,462 GBP2023-12-31
150,047 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-34,884 GBP2023-12-31
-6,037 GBP2022-12-31
Net Current Assets/Liabilities
75,578 GBP2023-12-31
144,010 GBP2022-12-31
Total Assets Less Current Liabilities
1,483,575 GBP2023-12-31
1,422,307 GBP2022-12-31
Creditors
Non-current, Amounts falling due after one year
-36,452 GBP2023-12-31
-42,071 GBP2022-12-31
Net Assets/Liabilities
1,339,781 GBP2023-12-31
1,290,684 GBP2022-12-31
Equity
Called up share capital
20,001 GBP2023-12-31
20,001 GBP2022-12-31
Share premium
1,151,269 GBP2023-12-31
1,151,269 GBP2022-12-31
Retained earnings (accumulated losses)
168,511 GBP2023-12-31
119,414 GBP2022-12-31
Equity
1,339,781 GBP2023-12-31
1,290,684 GBP2022-12-31
Intangible Assets - Gross Cost
Development expenditure
1,407,997 GBP2023-12-31
1,278,297 GBP2022-12-31
Intangible Assets
Development expenditure
1,407,997 GBP2023-12-31
1,278,297 GBP2022-12-31
Other Debtors
Current
12,804 GBP2023-12-31
14,534 GBP2022-12-31
Prepayments/Accrued Income
Current
38,000 GBP2023-12-31
38,000 GBP2022-12-31
Cash and Cash Equivalents
59,658 GBP2023-12-31
97,513 GBP2022-12-31
Bank Borrowings
Current
7,585 GBP2023-12-31
1,686 GBP2022-12-31
Trade Creditors/Trade Payables
Current
20,855 GBP2023-12-31
416 GBP2022-12-31
Taxation/Social Security Payable
Current
159 GBP2023-12-31
Other Creditors
Current
2,160 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
4,125 GBP2023-12-31
3,935 GBP2022-12-31
Creditors
Current
34,884 GBP2023-12-31
6,037 GBP2022-12-31
Bank Borrowings
Non-current
36,452 GBP2023-12-31
42,071 GBP2022-12-31
Creditors
Non-current
36,452 GBP2023-12-31
42,071 GBP2022-12-31
Bank Borrowings
Current, Amounts falling due within one year
7,585 GBP2023-12-31
1,686 GBP2022-12-31
Total Borrowings
Current, Amounts falling due within one year
7,585 GBP2023-12-31
1,686 GBP2022-12-31
Bank Borrowings
Non-current, Between one and two years
36,452 GBP2023-12-31
42,071 GBP2022-12-31
Total Borrowings
44,037 GBP2023-12-31
43,757 GBP2022-12-31
Net Deferred Tax Liability/Asset
-107,342 GBP2023-12-31
-89,552 GBP2022-12-31
-66,650 GBP2022-01-01
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
-17,790 GBP2023-01-01 ~ 2023-12-31
-22,902 GBP2022-01-01 ~ 2022-12-31
Deferred Tax Liabilities
Accelerated tax depreciation
-298,310 GBP2023-12-31
-278,125 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
10,627 shares2023-12-31
10,627 shares2022-12-31
Par Value of Share
Class 1 ordinary share
12023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
4,687 shares2023-12-31
4,687 shares2022-12-31
Par Value of Share
Class 2 ordinary share
12023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
4,687 shares2023-12-31
4,687 shares2022-12-31
Par Value of Share
Class 3 ordinary share
12023-01-01 ~ 2023-12-31
  • NEWTEC VASCULAR PRODUCTS LIMITED
    Info
    Registered number 08824446
    Fourth Floor Unit 5b The Parklands, Lostock, Bolton BL6 4SD
    Private Limited Company incorporated on 2013-12-23 (11 years 6 months). The company status is Liquidation.
    The last date of confirmation statement was made at 2023-12-23
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.